News | December 14, 2023
Venus Remedies expands global presence with marketing authorisation for enoxaparin from Azerbaijan
The company makes its maiden entry into Azerbaijan’s pharmaceutical market
The company makes its maiden entry into Azerbaijan’s pharmaceutical market
The acquisition will enable Cupid Limited to amplify its production capacity by 1.5 times the existing output
The acquisition will add 20,000 litres of installed biologics drug substance manufacturing capacity for Syngene
India had proposed for setting up the global standards for millets
The divestment is a part of Fortis' ongoing portfolio rationalization strategy
Expanded collaboration with Vanguard Renewables aims to significantly increase the productivity of US renewable natural gas generation
Sales in the US region grew well, partially offset by the decline in the LATAM and European regions
Q2FY24 EBITDA up by 105% y-o-y at Rs. 28 crore
Lack of technology transfer stands out as a formidable barrier
India is following a holistic and inclusive approach in alignment with the vison of Universal Health Coverage and the resolute commitment to ‘leave no one behind
Subscribe To Our Newsletter & Stay Updated
